Abstract Background In Europe, population-based data concerning perioperative treatment
(PT) and radical cystectomy (RC) are lacking. We assessed temporal trends in PT …

Background Neoadjuvant chemotherapy (NAC) is underutilized in the treatment of bladder
cancer (BC). Objective To investigate the effect of NAC on the risk of surgical complications …

Background Uptake of perioperative chemotherapy for muscle-invasive bladder cancer
(MIBC) has been historically poor. We describe contemporary use of neoadjuvant (NACT) …

Objective To review time‐trends in the use of perioperative chemotherapy and its impact on
oncological outcomes in patients with bladder urothelial cancer (UC) at a single tertiary …

Study Type–Therapy (case series) Level of Evidence 4 OBJECTIVE To evaluate data
obtained from a large, multi‐institutional, contemporary series of patients who underwent …

Background Although therapeutic guidelines recommend the use of neoadjuvant
chemotherapy before radical cystectomy (RC) in patients who have muscle-invasive bladder …

Purpose Despite the increasing number of studies confirming the importance of neoadjuvant
chemotherapy (NC) in patients before radical cystectomy (RC) for bladder cancer (BCa), NC …

Objective To determine whether use of neoadjuvant chemotherapy (NAC) is associated with
a higher risk of post-operative complications following radical cystectomy (RC) for bladder …

Background: The present study documents the natural history and outcomes of high-risk
bladder cancer after radical cystectomy (RC) in patients who did not receive neoadjuvant …

Background Few articles have documented regimens and timing of perioperative
chemotherapy for bladder cancer in routine practice. Here, we describe practice patterns in …